Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Thymoma × Proton Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Brain Neoplasms 6 Sarcoma 4 Carcinoma, Hepatocellular 4 Solid Tumor, Adult 3 Carcinoma, Non-Small-Cell Lung 3 Pituitary Neoplasms 2 Meningioma 2 Liver Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Thymus Neoplasms 1 Thymoma 1 Thoracic Neoplasms 1 Solid Tumor 1 Rhabdomyosarcoma 1 Recurrence 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Pediatric Cancer Patients 1 Parotid Neoplasms 1 Neuroblastoma 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Malignant Brain Glioma 1 Lymphoma, Non-Hodgkin 1

Interventions

Robotic Surgical Procedures 2 Thymectomy 1 Radiotherapy, Adjuvant 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Proton Therapy 1 Patient Comfort 1 Palliative Care 1 Magnetic Resonance Spectroscopy 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡